Lyell Immunopharma clinical trials we track

Check company identity source

Phase 3 1 trial

Phase 1 / 2 1 trial

TrialDrugs studiedStatusPrimary completion
LYL273 for Patients With Relapsed or Refractory mCRCNCT05319314LYL273Recruiting2028-06Estimated

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters